And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to depression ...

Turns out, Johnson & Johnson’s is not only ... by infusion into a vein for depression as it is only FDA-approved in the form of a nasal spray under direct medical supervision for this indication.

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

The U.S. Food and Drug Administration has approved the Sonu Band, an artificial intelligence-enabled, wearable medical device ...

WASHINGTON -- The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

June 2, 2025 -- The FDA has approved Moderna's new COVID-19 shot, an mRNA vaccine, with some limits on who can get it. The vaccine, called mNexspike, is for people who’ve previously received a ...

The vaccine is expected to be available this fall. The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to 64 years at high ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®. The new vaccine is indicated for active immunization to prevent COVID-19 caused ...

His wife, Karen Walsh, hovers over him, ready to depress the plunger on a nasal spray applicator ... into a clinical trial and have no other treatment options. When the FDA approved foralumab for ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen ...

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for nasal congestion relief.

“The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19,” CEO Stephane Bancel said in the statemen ...